![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2019
Mahli, Abdo; Thasler, Wolfgang Erwin und Hellerbrand, Claus
(2019):
Establishment of a p-nitrophenol oxidation-based assay for the analysis of CYP2E1 activity in intact hepatocytes in vitro.
In: Toxicology Mechanisms and Methods, Bd. 29, Nr. 3: S. 219-223
2018
Koletzko, Leandra; Mahli, Abdo und Hellerbrand, Claus
(2018):
Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism.
In: Pathology Research and Practice, Bd. 214, Nr. 10: S. 1700-1706
Mahli, Abdo; Saugspier, Michael; Koch, Andreas; Sommer, Judith; Dietrich, Peter; Lee, Seren; Thasler, Reinhard; Schulze-Luehrmann, Jan; Luehrmann, Anja; Thasler, Wolfgang Erwin; Müller, Martina; Bosserhoff, Anja und Hellerbrand, Claus
(2018):
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis.
In: Gut, Bd. 67, Nr. 4: S. 746-756
[PDF, 2MB]
Mahli, Abdo; Koch, Andreas; Fresse, Kim; Schiergens, Tobias; Thasler, Wolfgang Erwin; Schönberger, Christina; Bergheim, Ina; Bosserhoff, Anja und Hellerbrand, Claus
(2018):
Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis.
In: Laboratory Investigation, Bd. 98, Nr. 12: S. 1614-1626
Dietrich, Peter; Freese, Kim; Mahli, Abdo; Thasler, Wolfgang Erwin; Hellerbrand, Claus und Bosserhoff, Anja Katrin
(2018):
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.
In: Oncotarget, Bd. 9, Nr. 3: S. 3605-3618
2017
Sommer, Judith; Mahli, Abdo; Freese, Kim; Schiergens, Tobias S.; Kuecuekoktay, Fulya Suzan; Teufel, Andreas; Thasler, Wolfgang E.; Müller, Martina; Bosserhoff, Anja K. und Hellerbrand, Claus
(2017):
Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice.
In: Oncotarget, Bd. 8, Nr. 8: S. 13059-13072